Wall Street Zen upgraded shares of BIO-key International (NASDAQ:BKYI – Free Report) to a hold rating in a report issued on Saturday morning,Wall Street Zen reports.
BKYI has been the topic of several other reports. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of BIO-key International in a report on Thursday, October 15th. Zacks Research raised BIO-key International to a “hold” rating in a research note on Thursday, August 6th. One equities research analyst has rated the stock with a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Reduce”.
Get Our Latest Research Report on BKYI
BIO-key International Stock Performance
BKYI stock opened at $2.85 on Friday. The company has a fifty day moving average price of $2.60 and a 200-day moving average price of $4.65. The company has a market capitalization of $5.80 million, a P/E ratio of -0.69 and a beta of 0.50. BIO-key International has a 52-week low of $1.55 and a 52-week high of $19.70.
BIO-key International (NASDAQ:BKYI – Get Free Report) last issued its quarterly earnings data on Thursday, August 13th. The technology company reported ($0.56) earnings per share for the quarter, topping the consensus estimate of ($0.82) by $0.26. The company had revenue of $1.92 million for the quarter, compared to analysts’ expectations of $1.80 million. BIO-key International had a negative net margin of 50.01% and a negative return on equity of 67.31%. As a group, sell-side analysts forecast that BIO-key International will post -1.62 earnings per share for the current fiscal year.
About BIO-key International
BIO-key International, Inc (NASDAQ: BKYI) develops biometric identity and access-management solutions. Its technology enables organizations to authenticate users through fingerprints and other biometric credentials, helping replace or supplement passwords while supporting secure access to applications, networks and devices.
The company’s offerings include biometric readers and software, as well as identity and access-management platforms such as PortalGuard and WEB-key. These products are designed to support multifactor authentication, single sign-on, password management and identity verification across on-premises and cloud-based environments.
BIO-key serves businesses, government agencies, educational institutions and other organizations that require secure user authentication.
Further Reading
- Five stocks we like better than BIO-key International
- Comfort Systems Earnings: AI Slowdown or More Growth Ahead?
- Bristol Myers Squibb’s Cancer Breakthrough Could Have Implications Beyond Its Own Stock
- 5 Beaten-Down Growth Stocks Trading Like Value Plays as Cash Chases Mega-Caps
- Anthropic’s IPO Filing Reveals a Massive Opportunity for AI Infrastructure Giants
Receive News & Ratings for BIO-key International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BIO-key International and related companies with MarketBeat.com's FREE daily email newsletter.
